Financials
- Market Capitalization 3.66 B
- Employee 192
- Founded 2015
- CEO N/A
- Website www.relaytx.com
- Headquarter Delaware, United States
- FIGI BBG00DSS08K9
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1534 | CPRX Catalyst Pharmaceuticals, Inc. - Common Stock | 31.49 USD | +0.03% | +0.06% | +0.41% | +48.47% | 3.85 B USD | ||
| 1554 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.02 USD | +0.46% | -4.09% | +14.20% | +74.64% | 3.73 B USD | ||
| 1576 | GPCR Structure Therapeutics Inc - American Depositary Shares | 50.59 USD | -2.03% | -10.21% | +18.45% | +89.19% | 3.60 B USD | ||
| 1577 | DNLI Denali Therapeutics Inc. - Common Stock | 22.65 USD | -14.46% | -13.15% | +2.40% | +40.07% | 3.59 B USD |
Frequently asked questions about Relay Therapeutics, Inc. - Common Stock
What is the Relay Therapeutics, Inc. - Common Stock stock price today?
The current price of Relay Therapeutics, Inc. - Common Stock (RLAY) is 19.08. Over the past 24 hours, the stock has changed by +1.87%. Follow the RLAY chart for real-time price dynamics.
What is the stock ticker of Relay Therapeutics, Inc. - Common Stock?
Relay Therapeutics, Inc. - Common Stock trades under the ticker RLAY. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Relay Therapeutics, Inc. - Common Stock stock going up?
RLAY has changed by -3.20% over the last week, +27.28% over the last month, and +437.46% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Relay Therapeutics, Inc. - Common Stock net income for the last quarter?
Relay Therapeutics, Inc. - Common Stock reported net income of -73.29 M for the last quarter. The previous quarter showed -54.89 M, which means net income changed by -33.52%.
How many employees does Relay Therapeutics, Inc. - Common Stock have?
As of the latest available data, Relay Therapeutics, Inc. - Common Stock has 192 employees. Workforce size can provide additional context about the company's scale and operations.
What is Relay Therapeutics, Inc. - Common Stock EBITDA?
Relay Therapeutics, Inc. - Common Stock EBITDA is -78.87 M, and its EBITDA margin is -2 628.93%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Relay Therapeutics, Inc. - Common Stock stock?
You can buy Relay Therapeutics, Inc. - Common Stock (RLAY) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Relay Therapeutics, Inc. - Common Stock stock?
Investing in Relay Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RLAY chart and related analysis on metatrader.com as part of your research.